<?xml version="1.0" encoding="UTF-8"?>
<p id="p0065">In some centers, serology testing is being used to screen blood from those who have had and recovered from COVID-19 for the production of convalescent plasma, antibody-rich blood products that may be potential blood-based therapies for others with serious disease. There is some evidence that convalescent plasma may benefit people who are infected with COVID-19.</p>
